Latest News

ACQUIA: Acquia Unveils New Compliance, Security Capabilities for Acquia Cloud

Acquia today announced new capabilities for Acquia Cloud, extending the company’s strengths in security innovation and compliance for digital experience platforms. Additions include new tools to manage risk and updated compliance for a pair of key U.S.

EVERSOURCE ENERGY: Eversource Delivers Solar Power to the Grid, Bringing more Carbon-Free Energy to the Commonwealth

Following the construction of 19 new solar facilities across the commonwealth, Eversource is on track to deliver 62 megawatts of carbon-free, renewable energy to Bay State residents and businesses.

ABBOTT LABORATORIES: Abbott Brings its Proven Flu Fighters

Flu season typically peaks in February: Abbott's technologies are ready to fight back.

BOSTON SCIENTIFIC CORPORATION: Boston Scientific Participates in FDA General Issues Panel on Transvaginal Surgical Mesh for Pelvic Organ Prolapse

On February 12, 2019, the U.S. Food and Drug Administration (FDA) convened an advisory panel of experts to discuss the safety and effectiveness of surgical mesh placed transvaginally to treat pelvic organ prolapse (POP).

BOSTON SCIENTIFIC CORPORATION: VICI VENOUS STENT® System Demonstrates Positive Clinical Outcomes in Patients with Deep Venous Blockages

Today, Boston Scientific (NYSE: BSX) announced positive 12-month data demonstrating that patients who were treated with the VICI VENOUS STENT® System for iliac and femoral vein obstructions exhibited a high rate of patent, or open, target lesions.

ADVANCED MEDICAL STRATEGIES: Treatment for Rare Blood Clotting Disorder Shows Efficacy in Phase 3 Study

New phase 3 data showed positive results for caplacizumab (Cablivi) in the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) in adults, according to a study published in the New England Journal of Medicine.

ADVANCED MEDICAL STRATEGIES: Massachusetts Initiative Looks at Payment Plans for Novartis’ SMA Gene Therapy

Many of the new biologic drugs and gene therapies coming on the market have shockingly high prices.

ADVANCED MEDICAL STRATEGIES: FDA Creating Innovation Office to Speed Drug Development

The FDA is creating an office of drug development science to cut the cost of bringing new medicines to patients, BioCentury reports.

CENTAGE: How to Forecast Cash Flow

Businesses talk a lot about budgets, revenue projections, and actuals.

CAPE COD CANAL REGION CHAMBER OF COMMERCE: Mass. Coalition for Sustainable Energy

The Massachusetts Coalition for Sustainable Energy (MCSE) continues to add members.

ADVANCED MEDICAL STRATEGIES: Australian Researchers Develop 10-Minute Cancer Test

Researchers in Australia have developed a 10-minute test that can detect the presence of cancer cells anywhere in the human body, according to a newly published study.

AQUEDUCT TECHNOLOGIES: Aqueduct Earns Cisco Master Data Center and Hybrid Cloud Specialization

Aqueduct Technologies Inc. announced that it has met all requirements to achieve the Cisco® Master Data Center and Hybrid Cloud Specialization.

NEWTON-NEEDHAM REGIONAL CHAMBER: Fuller Commits Newton to Help Address Region's Housing Crisis

In an effort to address the region’s worsening housing crisis, Newton Mayor Ruthanne Fuller has joined a coalition of 15 local mayors who are to committed to creating 185,000 new units of housing across the region by the year 2030.

NOVARICA: DXP and aPaaS Systems Enabling Alternative Approaches for Agent Portals, Says Novarica

Many insurers current portals were developed more than a decade ago, and, insurer CIOs are looking to provide enhanced user experience as ease-of-doing-business remains a key competitive issue.

BOSTON SCIENTIFIC CORPORATION: Boston Scientific Prevails in German Edwards Lifesciences Litigation

Boston Scientific Corporation (NYSE: BSX) today announced the District Court of Dusseldorf, Germany has determined that Edwards Lifesciences Corporation's Sapien 3 Ultra™ device infringed a patent – established by Symetis SA, a subsidiary of Boston Scientific – specific to the fabric used on the valve seal, specifically the German part of European Patent (EP) 2 949 292 B1.

AQUEDUCT TECHNOLOGIES: Boom Times: Why 2018 Is Shaping Up To Be A Very Good Year

Aqueduct President & CEO, Manak Ahluwalia shares his insight with CRN into the state of the economy and the impact it is having on information technology spending and the solution provider landscape.

Metro Business Network